Showing posts with the label
Endo International
IndustryPRwire - Endo International announced that its subsidiary Endo Ventures Limited has entered into definitive agreements with Radius Health, Inc. (NASDAQ: RDUS) to register, commercialize and …
IndustryPRwire - Endo International announced that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt's Amit…
IndustryPRwire -- Endo International announced that it completed the previously announced acquisition of BioSpecifics Technologies Corp for $88.50 per share in an all-cash transaction, for an estima…
Endo International today announced it has agreed to acquire all of the outstanding shares of BioSpecifics Technologies Corp for $88.50 in cash per share, or an estimated enterprise value of approxim…
